$59.990
-1.878 (-3.13%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
XENE Prediction & Forecast by Similar Chart Analysis
Alphio's XENE stock price prediction model matches the current Xenon Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $62.01 (+3.36%). The 1-week path is $62.67 (+4.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Xenon Pharmaceuticals Inc Stock?
Xenon Pharmaceuticals is currently priced at $59.99, with a recent RSI of 38.054 indicating it is oversold. However, the company reported a significant net income loss of -$110.736 million in Q2 2026, which raises concerns about its financial health. While the stock has seen a year-to-date increase of +34.84%, the recent insider selling activity has surged by 904.19%, which could signal a lack of confidence among insiders. Given these factors, it may be prudent to hold off on buying until there are clearer signs of recovery and stability.
XENE stock price ended at $59.99 on Friday, after losing -3.13%
Xenon Pharmaceuticals Inc (XENE) last closed at $59.99, losing -3.13%. These facts feed the 1-day and 1-week XENE price prediction above.
Analyst Consensus
Xenon Pharmaceuticals Inc (XENE): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Xenon Pharmaceuticals Inc (XENE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches XENE, ranked by similarity.
Seasonality analysis for XENE
Historically the probability of a positive August return for XENE is 31.75%. December offers the highest probability of a positive month at 51.16%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.